Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Audentes Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    AUDENTES THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Audentes Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    600 California Street, 17th Floor San Francisco, CA 94108
    Telephone
    Telephone
    (415) 818-1001
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.audentestx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/audentes-therapeutics
    Twitter
    Twitter
    https://twitter.com/audentestx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Astellas writes down another piece of its Audentes gene therapy acquisition
    Astellas writes down another piece of its Audentes gene therapy acquisition

    https://endpts.com/astellas-books-450m-writedown-on-preclinical-gene-therapy-anemia-drug/

    Amber Tong ENDPTS
    16 Apr 2024
    Share Share
    FDA lifts clinical hold on Astellas Pompe gene therapy
    FDA lifts clinical hold on Astellas Pompe gene therapy

    https://www.fiercebiotech.com/biotech/astellas-after-years-gene-therapy-woes-gets-rare-boost-fda-lifting-pompe-clinical-hold#:~:text=The%20FDA%20has%20handed%20a,participant%20developed%20peripheral%20sensory%20neuropathy

    Nick Paul Taylor FIERCE BIOTECH
    21 Jan 2023
    Share Share
    Astellas takes $540M impairment charge over Audentes' gene therapy trial hold
    Astellas takes $540M impairment charge over Audentes' gene therapy trial hold

    https://www.fiercebiotech.com/biotech/astellas-takes-540m-impairment-charge-over-audentes-gene-therapy-trial-hold

    Ben Adams FIERCE BIOTECH
    28 Apr 2021
    Share Share
    Audentes Becomes Astellas Gene Therapies, Will Advance MD Treatments
    Audentes Becomes Astellas Gene Therapies, Will Advance MD Treatments

    https://musculardystrophynews.com/2021/04/06/audentes-becomes-astellas-gene-therapies-will-advance-treatments-for-muscular-dystrophy-md-other-conditions/

    Marta Figueiredo PhD MUSCULARDYSTROPHYNEWS
    02 Apr 2021
    Share Share
    Audentes CEO exits as Astellas rebrands a gene therapy buyout
    Audentes CEO exits as Astellas rebrands a gene therapy buyout

    https://www.biopharmadive.com/news/astellas-gene-therapy-audentes-holles-depart/597703/

    Ned Pagliarulo BIOPHARMADIVE
    01 Jan 2021
    Share Share
    Audentes sees FDA hold lifted after 3 trial deaths
    Audentes sees FDA hold lifted after 3 trial deaths

    https://www.fiercebiotech.com/biotech/takeda-audentes-see-fda-hold-lifted-after-three-trial-deaths-blighted-3b-program

    Ben Adams FIERCE BIOTECH
    31 Dec 2020
    Share Share
    Audentes sees FDA hold lifted after 3 trial deaths blighted $3B program
    Audentes sees FDA hold lifted after 3 trial deaths blighted $3B program

    https://www.fiercebiotech.com/biotech/takeda-audentes-see-fda-hold-lifted-after-three-trial-deaths-blighted-3b-program

    Ben Adams FIERCE BIOTECH
    29 Dec 2020
    Share Share
    Taysha Gene Therapies Builds Experienced Executive Leadership Team
    Taysha Gene Therapies Builds Experienced Executive Leadership Team

    https://www.businesswire.com/news/home/20200831005201/en/Taysha-Gene-Therapies-Builds-Experienced-Executive-Leadership

    BUSINESSWIRE
    31 Aug 2020
    Share Share
    Astellas' Audentes reports 3rd death in gene therapy trial
    Astellas' Audentes reports 3rd death in gene therapy trial

    https://www.fiercebiotech.com/biotech/astellas-audentes-reports-third-death-gene-therapy-trial

    Nick P. Taylor FIERCE BIOTECH
    22 Aug 2020
    Share Share
    Audentes Provides Update on the ASPIRO Clinical Trial Evaluating AT132
    Audentes Provides Update on the ASPIRO Clinical Trial Evaluating AT132

    https://www.businesswire.com/news/home/20200820005861/en

    BUSINESSWIRE
    21 Aug 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search